Homology Medicines Cash from Financing (Quarterly) Analysis

Homology Medicines Inc (DELISTED) (FIXX:DL)

0.9347 -15.76 (-94.40%) USD | NASDAQ | Mar 25, 16:00

0.92 -0.01 (-1.57%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.014M
September 30, 2023	0.018M
June 30, 2023	0.002M
March 31, 2023	0.15M
December 31, 2022	0.032M
September 30, 2022	0.124M
June 30, 2022	0.00
March 31, 2022	0.44M
December 31, 2021	0.001M
September 30, 2021	0.379M
June 30, 2021	49.75M
March 31, 2021	2.043M
December 31, 2020	52.00M
September 30, 2020	0.41M

Date	Value
June 30, 2020	0.241M
March 31, 2020	0.447M
December 31, 2019	22.58M
September 30, 2019	0.614M
June 30, 2019	134.70M
March 31, 2019	0.325M
December 31, 2018	0.041M
September 30, 2018	0.025M
June 30, 2018	151.89M
March 31, 2018	-0.958M
December 31, 2017	11.66M
September 30, 2017	83.09M
June 30, 2017	0.00
March 31, 2017	20.48M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum

Jun 2022

134.70M

Maximum

Jun 2019

13.89M

Average

0.379M

Median

Sep 2021

Cash from Financing (Quarterly) Benchmarks

Societal CDMO Inc (DELISTED)	-0.854M
AgeX Therapeutics Inc (DELISTED)	2.00M
NovaBay Pharmaceuticals Inc	-0.597M
Palatin Technologies Inc	9.136M
iBio Inc	5.025M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-21.58M
Cash from Investing (Quarterly)	31.72M
Free Cash Flow	-96.46M
Free Cash Flow Per Share (Quarterly)	-6.699
Free Cash Flow Yield	-3.21K%